• Boston University

Register for New Account

Register

For core clinical content designed to help you safely and effectively manage patients with chronic pain, when appropriate, with opioid analgesics, please visit our sister site, SCOPE of Pain.

 

  1. Optimizing Office Systems
  2. Office Systems Safe and Competent Opioid Prescribing: Optimizing Office Systems Program CME Post-Test Evaluation
  1. Massachusetts Laws
  2. Educational Program Making Sense of Massachusetts Opioid Prescribing Laws and State and National Guidelines Program CME Post-Test Evaluation
  1. Dental Pain
  2. Educational Program Safe Opioid Prescribing for
    Acute Dental Pain
    Program CME Post-Test Evaluation
  1. Prescribe to Prevent
  2. Educational Program Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists Information Program CME Post-Test Evaluation
  1. Military Modules
  2. Module 1 Military SCOPE of Pain: Safe and Competent Opioid Prescribing For Providers Working with Veterans and Military Service Personnel Information Video CME Post-Test Evaluation
  3. Module 2 Military SCOPE of Pain: Safe and Competent Opioid Prescribing For Providers Working with Veterans and Military Service Personnel Information Video CME Post-Test Evaluation
  1. Video Modules
  2. Module 1 Case Studies In Practice: Applying Principles
    of Safe Opioid Prescribing
    Information Introduction Cases Case I Case II Case III Certification CME Post-Test Evaluation
  3. Module 2 Complex Convrs. High Dose Opioids
    & Illicit Drug Use
    Information Introduction Cases Case I-A Case I-B Case II Certification CME Post-Test Evaluation
  4. Module 3 Using the PDMP PMP Questionable Activity Information Introduction Cases Case I Case II Certification CME Post-Test Evaluation

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Boston University School of Medicine and the Massachusetts Board of Registration in Medicine. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Boston University School of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity was planned in collaboration with the Massachusetts Department of Public Health, the Massachusetts Hospital Association, and the Massachusetts Medical Society.

This program meets the criteria of the Massachusetts Board of Registration in Medicine for 1 hour of risk management study.

This program meets the criteria of the Massachusetts Board of Registration in Medicine for 1 hour of opioid education.

In order to receive credit, participants must view the content of each module and complete the post-test and evaluation for each.  Participants who receive a grade of 70% or greater on the post-tests will receive credit.  Modules can be completed individually (each module is designated for 1 AMA PRA Category 1 Credit™).


[ View Full Accreditation Information ].

 

 

Educational Objectives

At the conclusion of this activity, participants will be able to:

  • Apply a practical framework for decision-making on the initiation, maintenance, and discontinuation of opioid analgesics for the treatment of chronic pain.

 

 

Faculty

Daniel P. Alford, MD, MPH, FACP (Course Director)
Professor of Medicine
Boston University School of Medicine
Boston Medical Center
Faculty member has nothing to disclose with regards to commercial support. Faculty member indicates that he does not discuss unlabeled/investigational uses of a commercial product.

dan.alford@bmc.org

 

Jeffrey Baxter, MD
Assistant Professor
Department of Family Medicine and Community Health
University of Massachusetts Medical School
Faculty member has nothing to disclose with regards to commercial support. Faculty member indicates that he does not discuss unlabeled/investigational uses of a commercial product.

jeff.baxter@umassmed.edu

 

Sheila E. Chapman, MD
Assistant Professor of Medicine
Boston Medical Center
Boston University School of Medicine
Faculty member has nothing to disclose with regards to commercial support. Faculty member indicates that he does not discuss unlabeled/investigational uses of a commercial product.

sheila.chapman@bmc.org

 

Jane Liebschutz, MD, MPH, FACP
Associate Professor of Medicine and Social and Behavioral Sciences
Boston University Schools of Medicine and Public Health
Boston Medical Center
Faculty member has nothing to disclose with regards to commercial support. Faculty member indicates that she does not discuss unlabeled/investigational uses of a commercial product.

jane.liebschutz@bmc.org

 

John A. Renner, Jr., MD
Associate Professor of Psychiatry
Boston University School of Medicine
Associate Chief of Psychiatry, VA Boston Healthcare System
Faculty member holds stock in Johnson & Johnson. Faculty member indicates that he does discuss the off label use of buprenorphine/naloxone for pain, and parzosin for PTSD related nightmares.

john.renner@va.gov



[ View All Faculty Members ]